Pharmaceutical care: (1) Essential hypertension

Pharmaceutical Journal

Volumn 260, Issue 6986, 1998, Pages 411-417

  Hudson, S ^a   McAnaw, J ^a   McGlynn, S ^a   Boyter, A ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

ESSENTIAL HYPERTENSION; HEALTH CARE; HUMAN; PHARMACEUTICAL CARE; PHARMACIST; PRACTICE GUIDELINE; REVIEW; TREATMENT PLANNING;

EID: 0032554488     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. American Society of Heath Systems Pharmacists, ASHP statement on pharmaceutical care. Ibid 1993;50:1720-3.
3. UK Clinical Pharmacy Association. Statement on pharmaceutical care. Pharm J 1996;256:345-6.
4. Hepler CD, Grainger-Rousseau TJ. Pharmaceutical care versus traditional drug treatment. Is there a difference? Drugs 1995;49:1-10.
5. Pharmaceutical Care: The future for community pharmacy. Report of the joint working party on the future role of community pharmaceutical services. London: Royal Pharmaceutical Society of Great Britain on behalf of the Department of Health and the pharmaceutical profession, 1992.
6. ASHP guidelines on a standardised method for pharmaceutical care. Am J Health Syst Pharm 1996;53:1713-6.
7. Cromarty J, editor. Clinical pharmacy in the hospital pharmaceutical service: a framework for practice. Scottish Office Department of Health, 1996.
8. SHEP co-operative research group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
9. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O, et al. STOP - Hypertension in older hypertensives. Lancet 1991;338:1281-5.
10. MSC working party. MRC trial in older hypertensives. BMJ 1992;304:405-12.
11. Syst-Eur investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.
12. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first line agents. A systematic review and meta-analysis. JAMA 1997; 277:739-45.
13. Fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153: 154-83.
14. Whelton P. Epidemiology of hypertension. Lancet 1994; 344:101-6.
15. Office for population censuses and surveys. Health Survey for England 1995.London: HM Stationary Office, 1997.
16. Scottisk Health Survey 1995. Scottish Office Department of Health. London: HM Stationary Office, 1997.
17. Health screening and health promotion; blood pressure measurement. Medicines, Ethics and Practice - a guide for pharmacists, No 19. London: Royal Pharmaceutical Society, 1998;107.
18. Petric JC, Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement. BMJ 1986;293:611-5.
19. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Ibid 1993;306:983-7.
20. Elnocki M, Kotchen TA. Hypertension: patient evaluation, indications for treatment. Geriatrics 1993;48:47-62.
21. Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmacol 1990;30:353-64.
22. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-7
23. Vandenburg MJ, Evans SJ, Kelly BJ, Bradshaw F, Currie WJ, Cooper WD. Factors affecting the reporting of symptoms by hypertensive patients. Br J Clin Pharmacol 1984:18 Suppl 2: 189S-195S.
24. Lip GY, Beevers DG. Doctors, nurses, pharmacists and patients - the rational evaluation and choice in hypertension (REACH) survey of hypertension care delivery. Blood Press 1997;6 Suppl 1:6-10.
25. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997;35:1164-70.
26. McKenney JM, SliningJM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with hypertension. Circulation 1973;48:1104-11.
27. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5.
28. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Effect of pharmacist intervention on control of resistant hypertension. Ibid 1986;43:905-8.
29. Menard PJ, Krishner BS, Kloth DD, et al. Management of the hypertensive patient by the pharmacist prescriber. Hosp Pharm 1986;21:20-8.
30. Dong BJ, Echaves SA, Brody RV, Shapiro DW. Pharmacist provision of preventive health care services in a hypertension clinic. Am J Health Syst Pharm 1997;54:564-6.